J. McDougall - 11 May 2021 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Director
Signature
/s/ Sam Backenroth, as attorney-in-fact for Gerald McDougall
Issuer symbol
NBSE
Transactions as of
11 May 2021
Net transactions value
$0
Form type
4
Filing time
13 May 2021, 18:03:15 UTC
Next filing
17 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Employee stock option (right to buy) Award $0 +92,219 $0.000000 92,219 11 May 2021 Common stock 92,219 $4.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the total shares shall vest on the first anniversary of the grant date, and 1/36th of the remaining shares shall vest on a monthly basis thereafter.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.